Facial Paralysis Market Revenue, Price and Gross Margin Study with Forecasts to 2027
Market Highlights Facial paralysis is a restriction of the facial movement due to nerve damage. Facial nerve paralysis is characterized by unilateral facial weakness. Some other symptoms include loss of taste, hyperacusis, and decreased salivation and tear secretion. Asia Pacific is the fastest growing market for facial paralysis whose growth is attributed to the rising population and increasing standard of living. Additionally, the increasing healthcare spending and the improved standard of living are likely to drive the growth of the market. India and China are the major contributors to the market growth due to the rapid development of healthcare infrastructure in these regions and the increasing demand for diagnostic services. The global facial paralysis market is expected to register a CAGR of 6.5% during the forecast period. Key Players Some of the key players in the facial paralysis market are, Boston Scientific, BioControl Medical, Cerebomed, Cyberonics, Astell...